Single Cell Glucose Uptake Assays: A Cautionary Tale

Linda V Sinclair1, Celine Barthelemy2, Doreen A Cantrell1

  • 1Division of Cell Signalling and Immunology, School of Life Sciences, University of Dundee, Dundee, DD1 4HN, UK.

Immunometabolism
|September 4, 2020
PubMed

Insights

The fluorescent glucose analog 2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)Amino)-2-Deoxyglucose (2-NBDG) is not a reliable measure of glucose transport in T cells. Its uptake does not correlate with actual glucose transport capacity in these immune cells.

Area of Science:

  • Immunology
  • Cellular Metabolism
  • Biochemistry

Background:

  • Assays for single-cell immune cell metabolic state and nutrient uptake are crucial.
  • 2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)Amino)-2-Deoxyglucose (2-NBDG) is a fluorescent glucose analog used to study glucose uptake.
  • 2-NBDG is validated for Glut2 but its selectivity for T cell glucose transporters (Glut1, Glut3) and non-transporter binding is unexplored.

Purpose of the Study:

  • To investigate the specificity of 2-NBDG labeling as a readout for glucose transport in T lymphocytes.
  • To assess whether 2-NBDG uptake accurately reflects glucose transport capacity in T cells.
  • To determine if 2-NBDG binds to T cells independently of glucose transporters.

Main Methods:

  • Comparison of flow cytometric 2-NBDG staining with radiolabeled glucose transport assays in murine T cells.
  • Assessment of 2-NBDG uptake inhibition by competitive substrates and glucose transporter inhibitors.
  • Evaluation of 2-NBDG's ability to competitively inhibit glucose uptake.

Main Results:

  • Significant discordance observed between glucose transport capacity and 2-NBDG labeling in T cells.
  • 2-NBDG uptake in murine T cells was not inhibited by known glucose transport inhibitors or competitive substrates.
  • 2-NBDG did not competitively block glucose uptake in T cells.

Conclusions:

  • 2-NBDG uptake alone is not a reliable tool for assessing cellular glucose transport capacity in T lymphocytes.
  • The mechanism of 2-NBDG uptake in T cells may not involve canonical glucose transporters.
  • Further research is needed to validate alternative methods for measuring T cell glucose uptake.